Latest & greatest articles for Pacemaker

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Pacemaker or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Pacemaker and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for Pacemaker

1. Switching Between Transcutaneous Pacemakers: Guidelines

Switching Between Transcutaneous Pacemakers: Guidelines Switching Between Transcutaneous Pacemakers: Guidelines | CADTH.ca Find the information you need Switching Between Transcutaneous Pacemakers: Guidelines Switching Between Transcutaneous Pacemakers: Guidelines Last updated: July 24, 2019 Project Number: RA1055-000 Product Line: Research Type: Devices and Systems Report Type: Reference List Result type: Report Question What are the evidence-based guidelines regarding care of transcutaneous (...) -paced adult patients who require switching to a different transcutaneous pacemaker? Key Message No relevant evidence-based guidelines were identified regarding care of transcutaneous-paced adult patients who require switching to a different transcutaneous pacemaker. Files Rapid Response Reference List Published : July 24, 2019 Follow us: © 2019 Canadian Agency for Drugs and Technologies in Health Get our newsletter:

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

2. Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE)

Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE) This trial aimed to evaluate the safety and efficiency of a common and simplified protocol for the surveillance of cardiac implantable electronic devices based on remote monitoring (RM) in patients with pacemakers (PMs) and implantable cardiac defibrillators (ICDs) for at least 24 months.The RM-ALONE is a multicentre

2019 EvidenceUpdates

3. A systematic review on the use of pacemakers in paediatrics

A systematic review on the use of pacemakers in paediatrics Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr

2019 PROSPERO

4. Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Permanent Pacemakers

Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Permanent Pacemakers Public Comment: Held April 5 to 26, 2018. Remote Monitoring of Implantable Cardioverter- Defibrillators, Cardiac Resynchronization Therapy, and Permanent Pacemakers: Health Quality Ontario Recommendation FINAL RECOMMENDATION • Health Quality Ontario, under the guidance of the Ontario Health Technology Advisory Committee, recommends publicly funding remote monitoring (...) for patients with implantable cardioverter-defibrillators, cardiac resynchronization therapy devices with or without a defibrillator, and permanent pacemakers RATIONALE FOR THE RECOMMENDATION There was consensus among the Ontario Health Technology Advisory Committee members that using remote monitoring improves clinical outcomes without affecting patients’ safety, it is good value for money, and patients report positive experiences with using remote monitoring. 1 Remote Monitoring of Implantable

2018 Health Quality Ontario

5. Leadless cardiac pacemaker implantation for bradyarrhythmias

Leadless cardiac pacemaker implantation for bradyarrhythmias L Leadless cardiac pacemak eadless cardiac pacemaker implantation for er implantation for br bradyarrh adyarrhythmias ythmias Interventional procedures guidance Published: 29 August 2018 nice.org.uk/guidance/ipg626 Y Y our responsibility our responsibility This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected (...) , and foster good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. 1 1 Recommendations Recommendations 1.1 Evidence on the safety of leadless cardiac pacemaker implantation for bradyarrhythmias shows

2018 National Institute for Health and Clinical Excellence - Interventional Procedures

6. Transvenous dual‐chamber pacemaker after paediatric heart transplantation using left ventricle pacing through the coronary sinus (PubMed)

Transvenous dual‐chamber pacemaker after paediatric heart transplantation using left ventricle pacing through the coronary sinus A 12-year-old child with end-stage heart failure due to restrictive cardiomyopathy was submitted to orthotopic heart transplantation. Primary graft dysfunction required venous arterial extra-corporeal membrane oxygenation. Heart function normalized, but complete atrioventricular block remained after 3 weeks. A dual-chamber pacing with transvenous left ventricle

Full Text available with Trip Pro

2018 ESC heart failure

7. Leadless pacemakers for right ventricle pacing. Update 2017

Leadless pacemakers for right ventricle pacing. Update 2017 Leadless pacemakers for right ventricle pacing. Update 2017 Leadless pacemakers for right ventricle pacing. Update 2017 Semlitsch T, Posch N Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Semlitsch T, Posch N. Leadless pacemakers for right ventricle pacing. Update 2017. Vienna (...) : Ludwig Boltzmann Institut fuer Health Technology Assessment (LBIHTA). Decision Support Document. 2017 Authors' objectives This report is the first update of the systematic review on "Leadless pacemakers for right ventricle pacing" prepared in March 2016. Leadless cardiac pacemakers are miniaturised, self-contained intracardiac devices that can be implanted entirely inside the right ventricle of the heart. The expected benefit is the avoidance of complications associated with external pulse generators

2017 Health Technology Assessment (HTA) Database.

8. End-of-life Management of Leadless Cardiac Pacemaker Therapy (PubMed)

End-of-life Management of Leadless Cardiac Pacemaker Therapy The clinically available leadless pacemakers for patients with a single-chamber pacing indication have shown to be safe and effective. However, the optimal end-of-life strategy of this novel technique is undefined. Suggested strategies comprise of (a) placing an additional leadless device adjacent to the leadless pacemaker, or (b) retrieving the non-functioning leadless pacemaker and subsequently implanting a new device. Although (...) initial studies demonstrate promising results, early experience of acute and mid-term retrieval feasibility and safety remains mixed. We suggest that the approach of leadless pacemaker retrieval is more appealing to limit the amount of non-functioning intracardiac hardware. In addition, potential risks for device-device interference, and unknown long-term complications associated with multiple intracardiac devices are prevented. The potential inability to retrieve chronically implanted leadless

Full Text available with Trip Pro

2017 Arrhythmia & electrophysiology review

9. Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator. (PubMed)

Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator. The presence of a cardiovascular implantable electronic device has long been a contraindication for the performance of magnetic resonance imaging (MRI). We established a prospective registry to determine the risks associated with MRI at a magnetic field strength of 1.5 tesla for patients who had a pacemaker or implantable cardioverter-defibrillator (ICD) that was "non-MRI-conditional" (i.e., not approved (...) settings.MRI was performed in 1000 cases in which patients had a pacemaker and in 500 cases in which patients had an ICD. No deaths, lead failures, losses of capture, or ventricular arrhythmias occurred during MRI. One ICD generator could not be interrogated after MRI and required immediate replacement; the device had not been appropriately programmed per protocol before the MRI. We observed six cases of self-terminating atrial fibrillation or flutter and six cases of partial electrical reset. Changes

Full Text available with Trip Pro

2017 NEJM

10. Naringenin inhibits pacemaking activity in interstitial cells of Cajal from murine small intestine (PubMed)

Naringenin inhibits pacemaking activity in interstitial cells of Cajal from murine small intestine Naringenin (NRG) is a common dietary polyphenolic constituent of fruits. NRG has diverse pharmacological activities, and is used in traditional medicine to treat various diseases including gastrointestinal (GI) disorders. Interstitial cells of Cajal (ICCs) are pacemaker cells of the GI tract. In this study, the authors investigated the effects of NRG on ICCs and on GI motility in vitro (...) and in vivo.ICCs were dissociated from mouse small intestines by enzymatic digestion. The whole-cell patch clamp configuration was used to record pacemaker potentials in cultured ICC clusters. The effects of NRG on GI motility were investigated by calculating percent intestinal transit rates (ITR) using Evans blue in normal mice.NRG inhibited ICC pacemaker potentials in a dose-dependent manner. In the presence of tetraethylammonium chloride or iberiotoxin, NRG had no effect on pacemaker potentials

Full Text available with Trip Pro

2017 Integrative medicine research

11. Micra transcatheter pacing system (Medtronic Inc.) for single-chamber pacemaker indications

Micra transcatheter pacing system (Medtronic Inc.) for single-chamber pacemaker indications Micra transcatheter pacing system (Medtronic Inc.) for single-chamber pacemaker indications Micra transcatheter pacing system (Medtronic Inc.) for single-chamber pacemaker indications HAYES, Inc Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc. Micra (...) transcatheter pacing system (Medtronic Inc.) for single-chamber pacemaker indications. Lansdale: HAYES, Inc. Healthcare Technology Brief Publication. 2017 Authors' conclusions Health Problem: Inadequate slow heart rates (i.e., bradycardia) due to atrioventricular (AV) dysfunction or sinus node dysfunction may result in hemodynamic consequences. A permanent cardiac pacemaker (PM) is the definitive treatment for symptomatic bradycardia that is not caused by underlying disorders or medication. However, overall

2017 Health Technology Assessment (HTA) Database.

13. Effect of New-Onset Left Bundle Branch Block After Transcatheter Aortic Valve Implantation (CoreValve) on Mortality, Frequency of Re-Hospitalization, and Need for Pacemaker

Effect of New-Onset Left Bundle Branch Block After Transcatheter Aortic Valve Implantation (CoreValve) on Mortality, Frequency of Re-Hospitalization, and Need for Pacemaker New-onset conduction disturbances are common after transcatheter aortic valve implantation (TAVI). The most common complication is left bundle branch block (LBBB). The clinical impact of new-onset LBBB after TAVI remains controversial. The aim of this study was to analyze the clinical impact of new-onset LBBB in terms (...) of mortality and morbidity (need for pacemakers and admissions for heart failure) at long-term follow-up. From April 2008 to December 2014, 220 patients who had severe aortic stenosis were treated with the implantation of a CoreValve prosthesis. Sixty-seven of these patients were excluded from the analysis, including 22 patients with pre-existing LBBB and 45 with a permanent pacemaker, implanted previously or within 72 hours of implantation. The remaining 153 patients were divided into 2 groups: group 1 (n

2016 EvidenceUpdates

14. Leadless pacemakers for right ventricle pacing

Leadless pacemakers for right ventricle pacing Leadless pacemakers for right ventricle pacing Leadless pacemakers for right ventricle pacing Kisser A, Emprechtinger R Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Kisser A, Emprechtinger R. Leadless pacemakers for right ventricle pacing. Vienna: Ludwig Boltzmann Institut fuer Health (...) Technology Assessment (LBIHTA). Decision Support Document No. 97. 2016 Project page URL Final publication URL Additional data URL Indexing Status Subject indexing assigned by CRD MeSH Cardiac Pacing, Artificial; Heart Ventricles; Humans; Pacemaker, Artificial Language Published English Country of organisation Austria English summary An English language summary is available. Address for correspondence Ludwig Boltzmann Institute fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7 rechte Stiege

2016 Health Technology Assessment (HTA) Database.

15. Pacemaker Essentials: How to Interpret a Pacemaker ECG

Pacemaker Essentials: How to Interpret a Pacemaker ECG Pacemaker Essentials: How to Interpret a Pacemaker ECG - CanadiEM Pacemaker Essentials: How to Interpret a Pacemaker ECG In , by Lorne Costello May 24, 2016 Is that pesky pacemaker still causing you trouble? It means well but sometimes it can rub emergency physicians the wrong way. Let’s shift our focus to the ECG, and hopefully we’ll discover some pearls to help us with these troublesome devices. This is part 2 of a 3 part series. Check (...) out part 1, “ ” if you haven’t already! If you’d like to download a personal version of the above infographic, . The Case It’s Saturday night and you are handed the following ECG. The patient is a 68-year-old male with chest pain. His past medical history is significant for a permanent pacemaker (PPM) that was placed for complete heart block three years ago. His vitals are stable. Does this person actually have a pacemaker? He could. This ECG shows normal sinus rhythm, and this does not rule out

2016 CandiEM

16. A Leadless Cardiac Pacemaker. (PubMed)

A Leadless Cardiac Pacemaker. 26863365 2016 02 11 2018 12 02 1533-4406 374 6 2016 02 11 The New England journal of medicine N. Engl. J. Med. A Leadless Cardiac Pacemaker. 594 10.1056/NEJMc1515015 Reddy Vivek Y VY eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Sep 17;373(12):1125-35 26321198 N Engl J Med. 2016 Feb 11;374(6):593-4 26863367 N Engl J Med. 2016 Feb 11;374(6):593 26863366 Arrhythmias, Cardiac therapy Female Humans Male Pacemaker, Artificial

2016 NEJM

17. A Leadless Cardiac Pacemaker. (PubMed)

A Leadless Cardiac Pacemaker. 26863366 2016 02 11 2018 12 02 1533-4406 374 6 2016 02 11 The New England journal of medicine N. Engl. J. Med. A Leadless Cardiac Pacemaker. 593 10.1056/NEJMc1515015 Bhargava Madhav M Bhargava Raghav R eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Sep 17;373(12):1125-35 26321198 N Engl J Med. 2016 Feb 11;374(6):594 26863365 Arrhythmias, Cardiac therapy Female Humans Male Pacemaker, Artificial 2016 2 11 6 0 2016 2 11 6 0

Full Text available with Trip Pro

2016 NEJM

18. A Leadless Cardiac Pacemaker. (PubMed)

A Leadless Cardiac Pacemaker. 26863367 2016 02 11 2018 12 02 1533-4406 374 6 2016 02 11 The New England journal of medicine N. Engl. J. Med. A Leadless Cardiac Pacemaker. 593-4 10.1056/NEJMc1515015 Xiao Yichao Y Zhou Shenghua S Liu Qiming Q eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Sep 17;373(12):1125-35 26321198 N Engl J Med. 2016 Feb 11;374(6):594 26863365 Arrhythmias, Cardiac therapy Female Humans Male Pacemaker, Artificial 2016 2 11 6 0 2016 2

Full Text available with Trip Pro

2016 NEJM

19. Syncope in Patients with Pacemakers (PubMed)

Syncope in Patients with Pacemakers Syncope in a pacemaker patient is a serious symptom but it is rarely due a pacemaker system malfunction. Syncope occurs in about 5 % of patients paced for atrioventricular (AV) block in 5 years, 18% in those paced for sinus node disease in 10 years, 20 % of those paced for carotid sinus syndrome in 5 years and 5-55 % of those older patients paced for vasovagal syncope in 2 years. The vastly different results in vasovagal syncope depend on the results of tilt (...) testing, where those with negative tests approach results in pacing for AV block and those with a positive tilt test show no better results than with no pacemaker. The implication of tilt results is that a hypotensive tendency is clearly demonstrated by tilt positivity pointing to syncope recurrence with hypotension. This problem may be addressed by treatment with vasoconstrictor drugs in those who are suited or, more commonly, a reduction or cessation of hypotensive therapy in hypertensive patients

Full Text available with Trip Pro

2015 Arrhythmia & electrophysiology review

20. Achilles' Lead: Will Pacemakers Break Free? (PubMed)

Achilles' Lead: Will Pacemakers Break Free? 26551666 2016 02 11 2018 12 02 1533-4406 374 6 2016 Feb 11 The New England journal of medicine N. Engl. J. Med. Achilles' Lead: Will Pacemakers Break Free? 585-6 10.1056/NEJMe1513625 Link Mark S MS From the Cardiac Arrhythmia Service, Tufts Medical Center, Boston. eng Editorial Comment 2015 11 09 United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Sep 17;373(12):1125-35 26321198 N Engl J Med. 2016 Feb 11;374(6):533-41 26551877 (...) Arrhythmias, Cardiac therapy Female Humans Male Pacemaker, Artificial 2015 11 10 6 0 2015 11 10 6 0 2016 2 13 6 0 ppublish 26551666 10.1056/NEJMe1513625

2015 NEJM